Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Pethe

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|November 30, 2021
<i>Call for Special Issue Papers:</i> Mycobacterial Cell-Envelope as a Target for Drug DevelopmentKevin Pethe, Michael Berney
Microbial Drug Resistance (Larchmont, N.Y.)|October 19, 2021
<i>Call for Special Issue Papers:</i> Mycobacterial Cell-Envelope as a Target for Drug DevelopmentKevin Pethe, Michael Berney
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Determination of Bioenergetic Parameters in Mycobacterium ulceransSangeeta Susan Thomas, Kevin Pethe
Expert Opinion on Investigational Drugs|January 17, 2022
Telacebec: an investigational antibacterial for the treatment of tuberculosis (TB)Bei Shi Lee, Kevin Pethe
Current Opinion in Pharmacology|July 18, 2018
Therapeutic potential of promiscuous targets in Mycobacterium tuberculosisBei Shi Lee, Kevin Pethe
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 9, 2016
Contribution of high-content imaging technologies to the development of anti-infective drugsMichelle Lay Teng Ang, Kevin Pethe
Current Opinion in Microbiology|May 26, 2023
Inhibiting respiration as a novel antibiotic strategyBei Shi Lee, Samsher Singh, Kevin Pethe
Chemistry & Biology|December 3, 2014
Targeting bacterial central metabolism for drug developmentPaul Murima, John D McKinney, Kevin Pethe
Progress in Biophysics and Molecular Biology|February 22, 2020
Targeting the cytochrome oxidases for drug development in mycobacteriaBei Shi Lee, Ekaterina Sviriaeva, Kevin Pethe
JACS Au|March 6, 2023
Chemical Basis of Combination Therapy to Combat Antibiotic ResistanceZhangyong Si, Kevin Pethe, Mary B Chan-Park
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Microbial Drug Resistance (Larchmont, N.Y.)|November 30, 2021
<i>Call for Special Issue Papers:</i> Mycobacterial Cell-Envelope as a Target for Drug DevelopmentKevin Pethe, Michael Berney
Microbial Drug Resistance (Larchmont, N.Y.)|October 19, 2021
<i>Call for Special Issue Papers:</i> Mycobacterial Cell-Envelope as a Target for Drug DevelopmentKevin Pethe, Michael Berney
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Determination of Bioenergetic Parameters in Mycobacterium ulceransSangeeta Susan Thomas, Kevin Pethe
Expert Opinion on Investigational Drugs|January 17, 2022
Telacebec: an investigational antibacterial for the treatment of tuberculosis (TB)Bei Shi Lee, Kevin Pethe
Current Opinion in Pharmacology|July 18, 2018
Therapeutic potential of promiscuous targets in Mycobacterium tuberculosisBei Shi Lee, Kevin Pethe
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 9, 2016
Contribution of high-content imaging technologies to the development of anti-infective drugsMichelle Lay Teng Ang, Kevin Pethe
Current Opinion in Microbiology|May 26, 2023
Inhibiting respiration as a novel antibiotic strategyBei Shi Lee, Samsher Singh, Kevin Pethe
Chemistry & Biology|December 3, 2014
Targeting bacterial central metabolism for drug developmentPaul Murima, John D McKinney, Kevin Pethe
Progress in Biophysics and Molecular Biology|February 22, 2020
Targeting the cytochrome oxidases for drug development in mycobacteriaBei Shi Lee, Ekaterina Sviriaeva, Kevin Pethe
JACS Au|March 6, 2023
Chemical Basis of Combination Therapy to Combat Antibiotic ResistanceZhangyong Si, Kevin Pethe, Mary B Chan-Park
Pageof 12